With a better understanding of biological systems and decoding of the genomes of major species, the deep connection between humans and animals has been established with the DNA we share, how our physiological systems function, and the underlying mechanism and pathophysiology of common diseases. Exploring the depth and breadth of this overlap is essential for solving critical diseases across species and has to be taken into account when developing animal therapeutics and diagnostics.
Although veterinary medicine and the development of animal therapeutics has evolved, many gaps still remain in the knowledge of animal science and the underlying mechanism of disease. Bridging the innovation gap between human medicine and veterinary medicine for the prevention, diagnosis, and treatment of animal diseases requires capturing the earliest signals of innovation across therapeutics, diagnostics, and technologies.
VetMeldTM provides unprecedented access to disruptive innovation across the value chain. It enhances the productivity of key stakeholders to ensure that any cross applications of human therapeutics to animal therapeutics are fully mapped and exploited. This ensures a better design of the most cutting edge treatment options for farm and pet animals.